Researchers develop chikungunya treatment
Director of the Vanderbilt Vaccine Center James Crowe, M.D. and his team are reporting the first large panel of antibody treatments against the chikungunya virus that has affected nearly 1.2 million people.
Video courtesy of Vanderbilt University
Follow BI Video: On Facebook
Director of the Vanderbilt Vaccine Center James Crowe, M.D. and his team are reporting the first large panel of antibody treatments against the chikungunya virus that has affected nearly 1.2 million people.
Video courtesy of Vanderbilt University
Follow BI Video: On Facebook